TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02700841

Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Study terminated prematurely due to poor recruitment.”

The sponsor’s own words in the registry.

Life of this trial

2016201720182019202020212022202320242025Registered2016-03-02Started2020-01-09Stopped2022-12-21Results posted2024-03-12

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
University of Nebraska
Sponsor type
University, hospital or other
Conditions
Plasma Cell Myeloma
Interventions
Melphalan; Peripheral Blood Stem Cell Transplantation--CD34 HSCT; Peripheral Blood Stem Cell Transplantation--AHSCT; T Cell-Depleted Hematopoietic Stem Cell Transplantation; Tetanus Toxoid Vaccine
Participants
8
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.